7PW1 image
Deposition Date 2021-10-05
Release Date 2022-04-06
Last Version Date 2024-01-31
Entry Detail
PDB ID:
7PW1
Keywords:
Title:
Crystal structure of ancestral haloalkane dehalogenase AncLinB-DmbA
Biological Source:
Source Organism:
Method Details:
Experimental Method:
Resolution:
1.50 Å
R-Value Free:
0.17
R-Value Work:
0.13
R-Value Observed:
0.14
Space Group:
P 43 21 2
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Haloalkane dehalogenase
Chain IDs:A
Chain Length:296
Number of Molecules:1
Biological Source:synthetic construct
Primary Citation
Structural Analysis of the Ancestral Haloalkane Dehalogenase AncLinB-DmbA.
Int J Mol Sci 22 ? ? (2021)
PMID: 34769421 DOI: 10.3390/ijms222111992

Abstact

Haloalkane dehalogenases (EC 3.8.1.5) play an important role in hydrolytic degradation of halogenated compounds, resulting in a halide ion, a proton, and an alcohol. They are used in biocatalysis, bioremediation, and biosensing of environmental pollutants and also for molecular tagging in cell biology. The method of ancestral sequence reconstruction leads to prediction of sequences of ancestral enzymes allowing their experimental characterization. Based on the sequences of modern haloalkane dehalogenases from the subfamily II, the most common ancestor of thoroughly characterized enzymes LinB from Sphingobium japonicum UT26 and DmbA from Mycobacterium bovis 5033/66 was in silico predicted, recombinantly produced and structurally characterized. The ancestral enzyme AncLinB-DmbA was crystallized using the sitting-drop vapor-diffusion method, yielding rod-like crystals that diffracted X-rays to 1.5 Å resolution. Structural comparison of AncLinB-DmbA with their closely related descendants LinB and DmbA revealed some differences in overall structure and tunnel architecture. Newly prepared AncLinB-DmbA has the highest active site cavity volume and the biggest entrance radius on the main tunnel in comparison to descendant enzymes. Ancestral sequence reconstruction is a powerful technique to study molecular evolution and design robust proteins for enzyme technologies.

Legend

Protein

Chemical

Disease

Primary Citation of related structures